CSF Profile | CSF pleocytosis group (WBC > 5cells/mm3) | Normocellular CSF group (WBC ≤ 5cells/mm3) |
---|---|---|
Days of CSF examination after neurological onset | Day 0—1: 5 (29.4 %) Day 2—10: 12 (70.6 %) | Day 0—1: 1 (16.7 %) Day 2—10: 5 (83.3 %) |
CSF protein | 0–60 mg/dl: 1 (6.3 %) 61–100 mg/dl: 7 (43.8 %) >100 mg/dl: 8 (50 %) Not available: 1 | 0–60 mg/dl: 2 (33.3 %) 61–100 mg/dl: 4 (66.7 %) >100 mg/dl: 0 |
CSF glucose | <30 mg/dl: 1 (6.3 %) 31–60 mg/dl: 7 (43.8 %) >60 mg/dl: 8 (50 %) Not available: 1 | <30 mg/dl: 0 31–60 mg/dl 1 (16.7 %) >60 mg/dl: 5 (83.3 %) |
Average CSF viral load | 12,200 copies/ml (39–11,755,813 copies/ml) (11 cases available: 6 had qualitative test) | 3027 copies/ml (59–5970 copies/ml) (4 cases available: 3 had qualitative test) |
Brain imaging findings | 16 available records | 6 available records |
Predominant temporal lobe lesions | 5 (29.4 %) | 1 (16.7 %) |
Fronto-temporal lesions | 4 (23.5 %) | 1 (16.7 %) |
Other cortical and subcortical lesions (non fronto-temporal)a | 3 (18.8 %) | 0 |
Fronto-temporal and thalamic lesionsa | 3 (18.8 %) | 0 |
Normal or Miscellaneousb | 0 | 2 (33.3 %) |
Normal CT (MRI not performed) | 1 (5.9 %) | 2 (33.3 %) |